Introduction
1,2-Dibromoethane (ethylene dibromide, EDB, ethylene bromide, CAS No. 106-93-4), a colorless volatile liquid, enjoys considerable use as a lead scavenger in leaded gasolines and as a soil and grain fumigant, mainly as a nematocide. The use of 1,2-dibromoethane as a fuel additive appears to be decreasing as leaded gasoline for automobiles is apparently being phased downward. Yet, more than 100 formulated pesticides contain EDB. In 1977, 120 million kilograms were produced in the United States. Lesser uses include as a dye intermediate, an industrial solvent (for resins, gums, waxes), and in some fire extinguishers.
1,2-Dibromoethane affects liver microsomes, DNA, and sperm. Human exposure to EDB can cause eye, skin and respiratory irritation as well as damage to the liver, kidney, spleen, and lungs.
Ethylene dibromide was mutagenic for Salmonella typhimurium G46, TA 1530 and TA 1535 without metabolic activation (1, 2) , for Drosophila melanogaster (3) and for Tradescantia (4) .
By the gavage route of administration, 1,2-dibromoethane was carcinogenic for OsborneMendel rats, causing squamous cell carcinomas of the forestomach in both sexes, hepatocellular carcinomas in females, and hemangiosarcomas of the circulatory system in males. EDB was carcinogenic in B6C3F1 mice, causing squamous cell carcinomas of the forestomach and alveolar/bronchiolar adenomas in both sexes (5) (6) (7) (8) (9) . These lesions were seen as early as week 12 in rats and week 24 in mice.
1,2-Dibromoethane was tested again by the National Toxicology Program/National Cancer Institute (NTP/NCI) Bioassay Program, this time using inhalation exposure to determine the effects by this route because workers and the general population are exposed to airborne EDB. All animals that died during the study or that were killed at the end of the exposure period were subjected to a gross necropsy and a complete histopathological examination. Statistical analyses of survival differences among groups were done using life table methods (10, 11) . For tumor incidence data, pairwise comparisons were made by Fisher's exact tests, and the significance of doseresponse trends was assessed by Cochran-Armitage tests (12, 13) . The study design conformed to the NCI Guidelinesfor Carcinogen Bioassays in Small Rodents (14) .
Results
Throughout the study, mean body weights of high dose rats and high dose mice of either sex were lower than those of the corresponding untreated controls. Survival of the high dose rats of either sex and of the low and high dose female mice was significantly shorter than that in the corresponding controls.
In male rats, 38/50 (76%) of the control group and 35/50 (70%) of the low dose group lived to the end of the study at 104-106 weeks. The high dose group was killed at week 89, at which time 5 Other than being chemically associated, the cause(s) of death in the rats and female mice was undetermined. The principal cause of early death in control and dosed male mice was ascending, suppurative urinary tract infection that resulted in necrotic, ulcerative lesions around the urethral opening, chronic or suppurative cystitis (often with urinary tract obstruction), and ascending suppurative pyelonephritis.
Exposure to 1,2-dibromoethane was also associated with hepatic necrosis and toxic nephropathy in rats or either sex, testicular degeneration in male rats, retinal degeneration in female rats, and epithelial hyperplasia of the respiratory system in mice.
Carcinomas and adenocarcinomas of the nasal cavity were observed with significantly increased incidences (p < 0.001) in high dose rats of either sex relative to controls. The incidences of adenocarcinomas and ademonas of the nasal cavity were also significantly increased (p < 0.001) in low dose rats of either sex. Adenomatous polyps of the nasal cavity showed a significantly increased incidence (p < 0.001) in low dose male rats. The combined incidence of alveolar/bronchiolar adenomas or carcinomas was statistically significant (p < 0.05) for high dose female rats.
Hemangiosarcomas of the circulatory system (mainly spleen) and mesotheliomas of the tunica vaginalis occurred in high dose male rats with significantly increased incidences (p < 0.001) relative to controls.
The incidence of fibroadenomas of the mammary gland was significantly elevated (p < 0.001) in dosed female rats compared to controls.
The incidences of alveolar/bronchiolar carcinoma and alveolar/bronchiolar adenoma were significantly increased (p < 0.001) in high dose male mice. These tumors were also increased in high-dose female mice (p < 0.01 for adenomas and p < 0.001 for carcinomas).
Hemangiosarcomas occurred in low and high dose female mice at incidences significantly greater (p < 0.001) than the incidence of the controls. High dose female mice also had significantly increased incidences of subcutaneous fibrosarcomas (p < 0.001), of nasal cavity carcinomas (p < 0.05), and of mammary gland adenocarcinomas (p < 0.05). Low dose female mice also showed a significantly increased incidence (p < 0.001) of mammary gland adenocarcinomas. bDose-related trend for females (p < 0.005).
'Greater than controls (p < 0.001).
dGreater than controls (p < 0.05).
eDose-related trend for females (p < 0.001).
'Adenoma, adenocarcinoma, adenomatous polyp, squamous cell papilloma, squamous cell carcinoma, papillary adenoma, carcinoma (individual tumor incidences are given in reference 17). gGreater than controls (p < 0.01). (15) reported compound-related nonneoplastic lesions in some of the same organs when rats were exposed to 1,2-dibromoethane in air at a concentration of 385 mg/m3 (50.2 ppm) for 7 hr per day, 5 days per week. Wong et al. (16) found testicular atrophy in 90% of male Sprague-Dawley rats exposed to a combination of EDB (20 ppm) and disulfiram (0.05%). In the NCI/NTP chronic study (17) , inflammation of the nasal cavity and epithelial hyperplasia of the respiratory system were diagnosed in dosed male and female mice. Using the 13-week observations, Reznik (18) reported finding characteristics of proliferative lesions in the nasal cavities of rats and mice. Stinson et al. (19) recorded similar findings in mice using data from the two-year study (17) . Other lesions observed in male mice were epithelial hyperplasia of the urinary bladder and inflammation of the prostate gland.
Nitschke et al. (20) exposed groups of ten CDF (F344) rats to 0, 3, 10, and 40 ppm EDB (five times per week) for 13 weeks; separate groups were held for another 13 weeks without additional exposure. The 3 ppm exposed group exhibited no observable lesions; the 10 ppm group showed hyperplasia of the nasal turbinates. Rats exposed to 40 ppm developed hyperplasia and nonkeratinizing squamous metaplasia of the respiratory epithelium. After the post exposure period these lesions were not observed in the rats exposed for the first 13 weeks.
Supernatant of rat liver homogenates contains an enzyme that catalyzes the reaction between glutathione and 1,2-dibromoethane (21); Watanabe et al. (22) have calculated that 20 mg 1,2-dibromoethane (by inhalation) would deplete the rat liver of glutathione.
According to Edwards et al. (23) , the small intestine, liver, kidney, and fat of male RF/Hiraki rats contained most of the radioactivity 3 hr after intraperitoneal injection of 1,2-14C-dibromoethane (40 mg/kg). When rats were given intraperitoneal injections of 1,2-14C-dibromoethane (4.2 mol) and killed after 24 hr, the largest amount of radioactivity was bound to protein, DNA, and RNA in the liver and kidney, and intermediate amounts were found in the lung, testes, stomach, and large and small intestines. Bromoacetaldehyde, an alkylating agent identified as a metabolite of 1,2-dibromoethane in rats, has been suggested to be the compound involved in the irreversible binding to protein and nucleic acid (24) .
1,2-Dibromoethane has been found to affect liver microsomes, DNA, and sperm. When liver microsomes from B6C3F1 mice and when DNA from salmon sperm were incubated with 14C-bromoacetaldehyde and 14C-bromoethanol, these metabolites of 1,2-dibromoethane were bound covalently to protein and DNA to a greater extent than was 1,2-dibromoethane (25) . After Nachtomi and Sarma (21) (26) .
In the NCI/NTP inhalation study (17) , tumors of the respiratory tract and tumors of the mammary gland were found at significantly increased incidences in EDB-dosed rats. Carcinomas, adenomatous polyps, and adenocarcinomas of the nasal cavity and hemangiosarcomas of the circulatory system in high dose rats of either sex occurred at incidences higher than those in the corresponding controls. Mesotheliomas of the tunica vaginalis in high dose male rats and mammary gland fibroadenomas and the combined incidence of alveolar/bronchiolar carcinomas and adenomas in high dose female rats all occurred at incidences higher than those in the corresponding controls.
In mice, as in dosed rats, tumors of the respiratory tract, (both sexes), hemangiosarcomas of the circulatory system (female), and tumors of the mammary gland (female) were found at significantly increased incidences. Alveolar/bronchiolar adenomas and alveolar/bronchiolar carcinomas in high dose male and female mice, and the combined incidence of carcinomas and adenomas of the nasal cavity, fibrosarcomas of the subcutaneous tissue, and hemangiosarcomas of the circulatory system in high dose female mice, occurred at incidences significantly higher than those in the corresponding controls.
In a chronic bioassay using Sprague-Dawley rats exposed by inhalation to 20 ppm EDB alone or in combination with disulfiram (0.05% diet), Wong et al. (16) Data analyses from a previous gavage study (6, 9, 27) , conducted in the same laboratory as the present study, showed increased incidences of squamous cell carcinomas of the forestomach in Osborne-Mendel rats and B6C3F1 mice of both sexes, hepatocellular carcinomas in female rats, hemangiosarcomas (primarily of the spleen) in male rats, and alveolar/bronchiolar adenomas in male and female mice. According to Van Duuren et al. (28) longterm (62 weeks) dermal application of EDB to Ha: ICR Swiss mice caused an increased incidence of respiratory tract tumors, skin papillomas, and skin carcinomas.
In conclusion and under the conditions of this bioassay (17) 1,2-dibromoethane was carcinogenic for F344 rats, causing increased incidences of carcinomas, adenocarcinomas, adenomas of the nasal cavity, and hemangiosarcomas of the circulatory system in males and females; mesotheliomas of the tunica vaginalis and adenomatous polyps of the nasal cavity in males; and fibroadenomas of the mammary gland and alveolar/bronchiolar adenomas and carcinomas (combined) in females. 1,2-Dibromoethane was carcinogenic for B6C3F1 mice, causing alveolar/bronchiolar carcinomas and alveolar/ bronchiolar adenomas in males and females; and hemangiosarcomas of the circulatory system, fibrosarcomas in the subcutaneous tissue, carcinomas of the nasal cavity, and adenocarcinomas of the mammary gland in females.
